nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Rifampicin—leprosy	0.733	1	CbGbCtD
Zoledronate—Anxiety depression—Thalidomide—leprosy	0.015	0.0598	CcSEcCtD
Zoledronate—Creatinine low—Thalidomide—leprosy	0.0128	0.0512	CcSEcCtD
Zoledronate—Blood creatinine decreased—Thalidomide—leprosy	0.0117	0.0468	CcSEcCtD
Zoledronate—Electrolyte imbalance—Thalidomide—leprosy	0.00588	0.0235	CcSEcCtD
Zoledronate—Proteinuria—Dapsone—leprosy	0.00546	0.0218	CcSEcCtD
Zoledronate—Protein urine present—Dapsone—leprosy	0.00538	0.0215	CcSEcCtD
Zoledronate—Toothache—Thalidomide—leprosy	0.00404	0.0161	CcSEcCtD
Zoledronate—Hypomagnesaemia—Thalidomide—leprosy	0.00387	0.0154	CcSEcCtD
Zoledronate—Interstitial lung disease—Thalidomide—leprosy	0.00347	0.0139	CcSEcCtD
Zoledronate—Pleural effusion—Thalidomide—leprosy	0.00321	0.0128	CcSEcCtD
Zoledronate—Hyperaesthesia—Thalidomide—leprosy	0.00313	0.0125	CcSEcCtD
Zoledronate—Nasopharyngitis—Dapsone—leprosy	0.00311	0.0124	CcSEcCtD
Zoledronate—Muscular weakness—Dapsone—leprosy	0.00307	0.0123	CcSEcCtD
Zoledronate—Influenza—Dapsone—leprosy	0.00301	0.012	CcSEcCtD
Zoledronate—Numbness—Thalidomide—leprosy	0.00296	0.0118	CcSEcCtD
Zoledronate—Sensory loss—Thalidomide—leprosy	0.00283	0.0113	CcSEcCtD
Zoledronate—Proteinuria—Thalidomide—leprosy	0.0028	0.0112	CcSEcCtD
Zoledronate—Protein urine present—Thalidomide—leprosy	0.00276	0.011	CcSEcCtD
Zoledronate—Musculoskeletal stiffness—Thalidomide—leprosy	0.00274	0.0109	CcSEcCtD
Zoledronate—Bone disorder—Thalidomide—leprosy	0.00272	0.0109	CcSEcCtD
Zoledronate—Hypocalcaemia—Thalidomide—leprosy	0.00268	0.0107	CcSEcCtD
Zoledronate—Bone pain—Thalidomide—leprosy	0.00256	0.0102	CcSEcCtD
Zoledronate—Neck pain—Thalidomide—leprosy	0.00249	0.00993	CcSEcCtD
Zoledronate—Hyperkalaemia—Thalidomide—leprosy	0.00241	0.00964	CcSEcCtD
Zoledronate—Candida infection—Thalidomide—leprosy	0.00234	0.00937	CcSEcCtD
Zoledronate—Blood urea increased—Thalidomide—leprosy	0.00232	0.00927	CcSEcCtD
Zoledronate—Oesophagitis—Thalidomide—leprosy	0.00224	0.00897	CcSEcCtD
Zoledronate—Erythema—Dapsone—leprosy	0.0021	0.00838	CcSEcCtD
Zoledronate—Vision blurred—Dapsone—leprosy	0.00198	0.0079	CcSEcCtD
Zoledronate—Eye pain—Thalidomide—leprosy	0.00197	0.00789	CcSEcCtD
Zoledronate—GGPS1—tendon—leprosy	0.00195	0.116	CbGeAlD
Zoledronate—Renal failure acute—Thalidomide—leprosy	0.00193	0.00772	CcSEcCtD
Zoledronate—Vertigo—Dapsone—leprosy	0.00188	0.00753	CcSEcCtD
Zoledronate—Atrial fibrillation—Thalidomide—leprosy	0.00188	0.00752	CcSEcCtD
Zoledronate—Arthritis—Thalidomide—leprosy	0.00183	0.00733	CcSEcCtD
Zoledronate—Cough—Dapsone—leprosy	0.00183	0.00731	CcSEcCtD
Zoledronate—Lethargy—Thalidomide—leprosy	0.00182	0.00727	CcSEcCtD
Zoledronate—Osteoarthritis—Thalidomide—leprosy	0.00178	0.00712	CcSEcCtD
Zoledronate—Pain in extremity—Thalidomide—leprosy	0.00178	0.00712	CcSEcCtD
Zoledronate—Tachycardia—Dapsone—leprosy	0.00167	0.00668	CcSEcCtD
Zoledronate—Blood creatinine increased—Thalidomide—leprosy	0.00167	0.00667	CcSEcCtD
Zoledronate—Dehydration—Thalidomide—leprosy	0.00166	0.00663	CcSEcCtD
Zoledronate—Hypokalaemia—Thalidomide—leprosy	0.00162	0.00648	CcSEcCtD
Zoledronate—GGPS1—testis—leprosy	0.00161	0.0958	CbGeAlD
Zoledronate—Cramp muscle—Thalidomide—leprosy	0.00161	0.00642	CcSEcCtD
Zoledronate—GGPS1—nervous system—leprosy	0.00158	0.0941	CbGeAlD
Zoledronate—Muscular weakness—Thalidomide—leprosy	0.00157	0.00628	CcSEcCtD
Zoledronate—Abdominal distension—Thalidomide—leprosy	0.00155	0.0062	CcSEcCtD
Zoledronate—Insomnia—Dapsone—leprosy	0.00155	0.00619	CcSEcCtD
Zoledronate—Influenza—Thalidomide—leprosy	0.00154	0.00616	CcSEcCtD
Zoledronate—Dysphagia—Thalidomide—leprosy	0.00154	0.00616	CcSEcCtD
Zoledronate—Bronchospasm—Thalidomide—leprosy	0.00152	0.00606	CcSEcCtD
Zoledronate—Pancytopenia—Thalidomide—leprosy	0.00146	0.00585	CcSEcCtD
Zoledronate—Neutropenia—Thalidomide—leprosy	0.00144	0.00576	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Thalidomide—leprosy	0.00143	0.00572	CcSEcCtD
Zoledronate—Pollakiuria—Thalidomide—leprosy	0.00142	0.00569	CcSEcCtD
Zoledronate—Weight increased—Thalidomide—leprosy	0.0014	0.0056	CcSEcCtD
Zoledronate—Gastrointestinal pain—Dapsone—leprosy	0.0014	0.00559	CcSEcCtD
Zoledronate—Weight decreased—Thalidomide—leprosy	0.00139	0.00557	CcSEcCtD
Zoledronate—Infestation NOS—Thalidomide—leprosy	0.00137	0.00549	CcSEcCtD
Zoledronate—Infestation—Thalidomide—leprosy	0.00137	0.00549	CcSEcCtD
Zoledronate—CA12—eye—leprosy	0.00137	0.0815	CbGeAlD
Zoledronate—Depression—Thalidomide—leprosy	0.00137	0.00547	CcSEcCtD
Zoledronate—FDPS—eye—leprosy	0.00136	0.0806	CbGeAlD
Zoledronate—Body temperature increased—Dapsone—leprosy	0.00135	0.00541	CcSEcCtD
Zoledronate—Abdominal pain—Dapsone—leprosy	0.00135	0.00541	CcSEcCtD
Zoledronate—Renal failure—Thalidomide—leprosy	0.00135	0.0054	CcSEcCtD
Zoledronate—Stomatitis—Thalidomide—leprosy	0.00134	0.00535	CcSEcCtD
Zoledronate—Conjunctivitis—Thalidomide—leprosy	0.00134	0.00534	CcSEcCtD
Zoledronate—Haematuria—Thalidomide—leprosy	0.00131	0.00523	CcSEcCtD
Zoledronate—Agranulocytosis—Thalidomide—leprosy	0.00128	0.00512	CcSEcCtD
Zoledronate—Bradycardia—Thalidomide—leprosy	0.00126	0.00502	CcSEcCtD
Zoledronate—Hypoaesthesia—Thalidomide—leprosy	0.00123	0.0049	CcSEcCtD
Zoledronate—Urinary tract disorder—Thalidomide—leprosy	0.00122	0.00487	CcSEcCtD
Zoledronate—Oedema peripheral—Thalidomide—leprosy	0.00121	0.00485	CcSEcCtD
Zoledronate—Urethral disorder—Thalidomide—leprosy	0.00121	0.00483	CcSEcCtD
Zoledronate—FDPS—skin of body—leprosy	0.00118	0.0701	CbGeAlD
Zoledronate—CA14—tendon—leprosy	0.00116	0.0692	CbGeAlD
Zoledronate—Eye disorder—Thalidomide—leprosy	0.00115	0.00461	CcSEcCtD
Zoledronate—Cardiac disorder—Thalidomide—leprosy	0.00114	0.00457	CcSEcCtD
Zoledronate—Angiopathy—Thalidomide—leprosy	0.00112	0.00447	CcSEcCtD
Zoledronate—Immune system disorder—Thalidomide—leprosy	0.00111	0.00445	CcSEcCtD
Zoledronate—Mediastinal disorder—Thalidomide—leprosy	0.00111	0.00444	CcSEcCtD
Zoledronate—Chills—Thalidomide—leprosy	0.00111	0.00442	CcSEcCtD
Zoledronate—Arrhythmia—Thalidomide—leprosy	0.0011	0.0044	CcSEcCtD
Zoledronate—Alopecia—Thalidomide—leprosy	0.00109	0.00435	CcSEcCtD
Zoledronate—Vomiting—Dapsone—leprosy	0.00109	0.00435	CcSEcCtD
Zoledronate—Mental disorder—Thalidomide—leprosy	0.00108	0.00432	CcSEcCtD
Zoledronate—Malnutrition—Thalidomide—leprosy	0.00107	0.00429	CcSEcCtD
Zoledronate—Headache—Dapsone—leprosy	0.00107	0.00428	CcSEcCtD
Zoledronate—Dysgeusia—Thalidomide—leprosy	0.00105	0.0042	CcSEcCtD
Zoledronate—Back pain—Thalidomide—leprosy	0.00104	0.00415	CcSEcCtD
Zoledronate—Muscle spasms—Thalidomide—leprosy	0.00103	0.00412	CcSEcCtD
Zoledronate—Nausea—Dapsone—leprosy	0.00102	0.00406	CcSEcCtD
Zoledronate—Vision blurred—Thalidomide—leprosy	0.00101	0.00404	CcSEcCtD
Zoledronate—Tremor—Thalidomide—leprosy	0.00101	0.00402	CcSEcCtD
Zoledronate—Ill-defined disorder—Thalidomide—leprosy	0.000996	0.00398	CcSEcCtD
Zoledronate—Anaemia—Thalidomide—leprosy	0.000992	0.00397	CcSEcCtD
Zoledronate—Agitation—Thalidomide—leprosy	0.000987	0.00394	CcSEcCtD
Zoledronate—Angioedema—Thalidomide—leprosy	0.000981	0.00392	CcSEcCtD
Zoledronate—Malaise—Thalidomide—leprosy	0.000968	0.00387	CcSEcCtD
Zoledronate—Vertigo—Thalidomide—leprosy	0.000965	0.00385	CcSEcCtD
Zoledronate—Syncope—Thalidomide—leprosy	0.000963	0.00385	CcSEcCtD
Zoledronate—Leukopenia—Thalidomide—leprosy	0.000961	0.00384	CcSEcCtD
Zoledronate—Palpitations—Thalidomide—leprosy	0.000949	0.00379	CcSEcCtD
Zoledronate—Loss of consciousness—Thalidomide—leprosy	0.000944	0.00377	CcSEcCtD
Zoledronate—Cough—Thalidomide—leprosy	0.000937	0.00374	CcSEcCtD
Zoledronate—Convulsion—Thalidomide—leprosy	0.00093	0.00372	CcSEcCtD
Zoledronate—Hypertension—Thalidomide—leprosy	0.000927	0.0037	CcSEcCtD
Zoledronate—Myalgia—Thalidomide—leprosy	0.000914	0.00365	CcSEcCtD
Zoledronate—Arthralgia—Thalidomide—leprosy	0.000914	0.00365	CcSEcCtD
Zoledronate—Chest pain—Thalidomide—leprosy	0.000914	0.00365	CcSEcCtD
Zoledronate—Anxiety—Thalidomide—leprosy	0.000911	0.00364	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000908	0.00363	CcSEcCtD
Zoledronate—Discomfort—Thalidomide—leprosy	0.000903	0.00361	CcSEcCtD
Zoledronate—FDPS—tendon—leprosy	0.000898	0.0534	CbGeAlD
Zoledronate—Dry mouth—Thalidomide—leprosy	0.000894	0.00357	CcSEcCtD
Zoledronate—Confusional state—Thalidomide—leprosy	0.000883	0.00353	CcSEcCtD
Zoledronate—Oedema—Thalidomide—leprosy	0.000876	0.0035	CcSEcCtD
Zoledronate—Infection—Thalidomide—leprosy	0.00087	0.00348	CcSEcCtD
Zoledronate—Shock—Thalidomide—leprosy	0.000862	0.00344	CcSEcCtD
Zoledronate—Nervous system disorder—Thalidomide—leprosy	0.000859	0.00343	CcSEcCtD
Zoledronate—Thrombocytopenia—Thalidomide—leprosy	0.000858	0.00343	CcSEcCtD
Zoledronate—Tachycardia—Thalidomide—leprosy	0.000855	0.00342	CcSEcCtD
Zoledronate—Skin disorder—Thalidomide—leprosy	0.000851	0.0034	CcSEcCtD
Zoledronate—Hyperhidrosis—Thalidomide—leprosy	0.000847	0.00338	CcSEcCtD
Zoledronate—Anorexia—Thalidomide—leprosy	0.000835	0.00334	CcSEcCtD
Zoledronate—Hypotension—Thalidomide—leprosy	0.000819	0.00327	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Thalidomide—leprosy	0.000798	0.00319	CcSEcCtD
Zoledronate—Insomnia—Thalidomide—leprosy	0.000792	0.00317	CcSEcCtD
Zoledronate—Paraesthesia—Thalidomide—leprosy	0.000787	0.00314	CcSEcCtD
Zoledronate—Dyspnoea—Thalidomide—leprosy	0.000781	0.00312	CcSEcCtD
Zoledronate—Somnolence—Thalidomide—leprosy	0.000779	0.00311	CcSEcCtD
Zoledronate—Dyspepsia—Thalidomide—leprosy	0.000771	0.00308	CcSEcCtD
Zoledronate—Decreased appetite—Thalidomide—leprosy	0.000762	0.00304	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Thalidomide—leprosy	0.000756	0.00302	CcSEcCtD
Zoledronate—Fatigue—Thalidomide—leprosy	0.000755	0.00302	CcSEcCtD
Zoledronate—Constipation—Thalidomide—leprosy	0.000749	0.00299	CcSEcCtD
Zoledronate—Pain—Thalidomide—leprosy	0.000749	0.00299	CcSEcCtD
Zoledronate—FDPS—testis—leprosy	0.000744	0.0442	CbGeAlD
Zoledronate—CA12—nervous system—leprosy	0.000738	0.0438	CbGeAlD
Zoledronate—FDPS—nervous system—leprosy	0.00073	0.0434	CbGeAlD
Zoledronate—Feeling abnormal—Thalidomide—leprosy	0.000722	0.00289	CcSEcCtD
Zoledronate—Gastrointestinal pain—Thalidomide—leprosy	0.000716	0.00286	CcSEcCtD
Zoledronate—CA2—eye—leprosy	0.000704	0.0418	CbGeAlD
Zoledronate—Urticaria—Thalidomide—leprosy	0.000696	0.00278	CcSEcCtD
Zoledronate—Abdominal pain—Thalidomide—leprosy	0.000693	0.00277	CcSEcCtD
Zoledronate—Body temperature increased—Thalidomide—leprosy	0.000693	0.00277	CcSEcCtD
Zoledronate—Hypersensitivity—Thalidomide—leprosy	0.000646	0.00258	CcSEcCtD
Zoledronate—Asthenia—Thalidomide—leprosy	0.000629	0.00251	CcSEcCtD
Zoledronate—Pruritus—Thalidomide—leprosy	0.00062	0.00248	CcSEcCtD
Zoledronate—CA2—skin of body—leprosy	0.000613	0.0364	CbGeAlD
Zoledronate—Diarrhoea—Thalidomide—leprosy	0.0006	0.0024	CcSEcCtD
Zoledronate—Dizziness—Thalidomide—leprosy	0.000579	0.00232	CcSEcCtD
Zoledronate—Vomiting—Thalidomide—leprosy	0.000557	0.00223	CcSEcCtD
Zoledronate—Rash—Thalidomide—leprosy	0.000552	0.00221	CcSEcCtD
Zoledronate—Dermatitis—Thalidomide—leprosy	0.000552	0.00221	CcSEcCtD
Zoledronate—Headache—Thalidomide—leprosy	0.000549	0.00219	CcSEcCtD
Zoledronate—ABCC1—tendon—leprosy	0.000522	0.031	CbGeAlD
Zoledronate—Nausea—Thalidomide—leprosy	0.00052	0.00208	CcSEcCtD
Zoledronate—CA2—tendon—leprosy	0.000466	0.0277	CbGeAlD
Zoledronate—ABCC1—testis—leprosy	0.000432	0.0257	CbGeAlD
Zoledronate—CA2—testis—leprosy	0.000386	0.0229	CbGeAlD
Zoledronate—CA2—nervous system—leprosy	0.000379	0.0225	CbGeAlD
